Skip to main content
Nirmish Shah, MD, Medicine/Pediatrics, Durham, NC, Duke University Hospital

NirmishShahMD

Medicine/Pediatrics Durham, NC

Associate Professor at Duke University

Dr. Shah is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Shah's full profile

Already have an account?

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Pediatric Hematology/Oncology, 2010
  • Vidant Medical Center/East Carolina University
    Vidant Medical Center/East Carolina UniversityResidency, Internal Medicine/Pediatrics, 2000 - 2004
  • American University of the Caribbean School of Medicine
    American University of the Caribbean School of MedicineClass of 2000

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2000 - 2024

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Effects of Red Blood Cell (RBC) Transfusion on Sickle Cell Disease Recipient Plasma and RBC Metabolism  
    Nirmish Shah, Ian Welsby, Reed Kamyszek, Andrea Ansari, Transfusion
  • Transition to Adult Care in Sickle Cell Disease: A Longitudinal Study of Clinical Characteristics and Disease Severity  
    Nirmish Shah, Gary Maslow, Pediatric Blood & Cancer

Press Mentions

  • GBT Presents Positive New Data on Oxbryta® (Voxelotor) in Patients with Sickle Cell Disease at ASH Annual Meeting and Exposition
    GBT Presents Positive New Data on Oxbryta® (Voxelotor) in Patients with Sickle Cell Disease at ASH Annual Meeting and ExpositionDecember 12th, 2021
  • Development of a Severity Classification System for Sickle Cell Disease
    Development of a Severity Classification System for Sickle Cell DiseaseOctober 28th, 2020
  • Treating Sickle Cell Disease with HSCT
    Treating Sickle Cell Disease with HSCTFebruary 19th, 2020
  • Join now to see all

Hospital Affiliations